# DrugMint: A Resource for Identifying Drug-like Molecules

**DrugMint** is a specialized computational platform designed to differentiate between drug-like and non-drug-like compounds. This resource is particularly valuable in the early stages of drug discovery,
where it helps prioritize small molecules that have the potential to become effective oral medications.

**Web Server:** https://webs.iiitd.edu.in/oscadd/drugmint/index.php


## Citation

Dhanda, S.K., Singla, D., Mondal, A.K. et al.  **DrugMint: A web server for predicting and designing drug-like molecules.** *Biology Direct*, 8:28. [https://doi.org/10.1186/1745-6150-8-28](https://doi.org/10.1186/1745-6150-8-28) 

This dataset is also available on Zenodo at https://doi.org/10.5281/zenodo.20094770

## About the Research

Identifying "drug-likeness" is essential to avoid late-stage clinical failures caused by poor pharmacokinetic properties. While traditional methods like Lipinski’s "Rule of Five" provide general guidelines,
DrugMint uses a more sophisticated machine learning approach to analyze the structural and chemical features of a molecule.

* **Diverse Dataset:** The model was developed using a large dataset of **FDA-approved drugs** (representing drug-like compounds) and a collection of **metabolites and common chemicals** (representing non-drug-like compounds).


* **Methodology:** The platform utilizes **Support Vector Machine (SVM)** algorithms based on molecular descriptors and fingerprints.



## Key Features

### 1. Robust Predictive Models

* **Multiple Descriptors:** Analyzes molecules based on various physicochemical properties such as molecular weight, logP, number of hydrogen bond donors/acceptors, and rotatable bonds.


* **Fingerprint Analysis:** Uses chemical fingerprints to capture the structural patterns associated with successful drugs.


* **High Accuracy:** The SVM models achieved high precision in discriminating drugs from non-drugs, providing a more reliable assessment than simple rule-based filters.



### 2. Design and Optimization

* **Lead Optimization:** Users can analyze chemical analogs to see how structural modifications impact the drug-likeness score.


* **Virtual Screening:** Capable of screening large libraries of compounds to identify potential lead candidates for further experimental testing.



### 3. Integrated Web-Bench

* **Predictive Module:** Submit a chemical structure (in SMILES or SDF format) to receive a drug-likeness prediction and score.


* **Property Analysis:** Provides a detailed breakdown of the physicochemical properties contributing to the molecule's classification.



## Applications

* **Early Drug Discovery:** Prioritizing compounds for synthesis and biological testing based on their predicted pharmacokinetic viability.


* **Library Filtering:** Cleaning and filtering chemical libraries to remove compounds with "undesirable" or "non-drug" characteristics.


* **Educational Use:** Helping students and researchers understand the chemical requirements for a small molecule to function as a drug.



## Contact & Authors

Prof. Gajendra P. S. Raghava (Corresponding Author)

raghava@iiitd.ac.in

Department of Computational Biology, Indraprastha Institute of Information Technology (IIIT Delhi), New Delhi, India.

## Support

The development of DrugMint was supported by the **Council of Scientific and Industrial Research (CSIR)** and the **Department of Biotechnology (DBT)**, Government of India.
